Anti-adalimumab Antibodies in Patients with Non-infectious Ocular Inflammatory Disease: A Case Series.

McKay, K Matthew; Apostolopoulos, Nicholas; Chou, Brian; Leveque, Thellea K; Van Gelder, Russell N

McKay, K Matthew; Apostolopoulos, Nicholas; Chou, Brian; Leveque, Thellea K; Van Gelder, Russell N.

Afiliação

McKay KM; Department of Ophthalmology, University of Washington, Seattle, Washington, USA.
Apostolopoulos N; Karalis Johnson Retina Center, Seattle, Washington, USA.
Chou B; Department of Ophthalmology and Visual Science, Yale University, New Haven, Connecticut, USA.
Leveque TK; Department of Ophthalmology, University of Washington, Seattle, Washington, USA.
Van Gelder RN; Department of Ophthalmology, University of Washington, Seattle, Washington, USA.

Ocul Immunol Inflamm ; 30(7-8): 1721-1725, 2022.

Article em En | MEDLINE | ID: mdl-34270383

Assuntos

Adalimumab; Humanos; Adalimumab/uso terapêutico; Exacerbação dos Sintomas

Palavras-chave

AAA; ADAb; Ocular inflammation; adalimumab; anti-adalimumab antibodies; anti-drug antibodies; biologics; immunogenicity; laboratory testing; uveitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adalimumab Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adalimumab Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article